Condition
Lice Infestations
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (2)
P 4 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05565820Phase 4Completed
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
NCT00291057Phase 2TerminatedPrimary
Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
NCT00244439Phase 3CompletedPrimary
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
NCT00819520Phase 3CompletedPrimary
Ivermectin in the Treatment of Head Lice
Showing all 4 trials